<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Knauer on Bioecon</title><link>https://en.bioecon.ru/companies/knauer/</link><description>Recent content in Knauer on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Sun, 26 Jul 2026 12:15:59 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/knauer/index.xml" rel="self" type="application/rss+xml"/><item><title>mRNA / LNP manufacturing equipment</title><link>https://en.bioecon.ru/technology/mrna-lnp-manufacturing-equipment/</link><pubDate>Sat, 25 Jul 2026 20:35:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/mrna-lnp-manufacturing-equipment/</guid><description>The mixers, skids and continuous-flow reactors that bring an mRNA payload and a four-lipid ethanol blend together in microseconds to self-assemble 80–120 nm lipid nanoparticles — the hardware layer behind every commercial mRNA vaccine and the in-vivo delivery system for the next generation of gene therapy.</description></item></channel></rss>